Titan Biotech Recommends 1:4 Bonus Issue

Titan Biotech's Board of Directors has approved a bonus issue of equity shares in a 1:4 ratio, subject to shareholder and regulatory approvals. The company also approved an increase in its authorized share capital to accommodate the bonus issue. Additionally, the Board recommended the re-appointment of Mr. Rohit Jain as an Independent Director for a second term and scheduled the 34th Annual General Meeting for September 29, 2026. The record date for the AGM and dividend payment is September 22, 2026, with book closure from September 23-29, 2026. A final dividend of Rs. 0.50 per share was also recommended.